| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
9 companies
Opaleye Management Inc. serves as a 10% Owner at OCUL and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 230 buys and 102 sells. Those positions are worth an estimated $124.7M at current prices.
Historically, Opaleye Management Inc.'s trades have earned a middling insider score of 60/100 across 182 rated trades. Over a 12-month horizon, 45.4% of those trades were profitable, with an average 12-month return of +3.5%.
The biggest single holding is OCUL (~$45.1M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 35,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 10, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 61,992 | $1.84 | $114,250.89 | -1.4% | +285.5% | +79.8% | |
| Jul 16, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 11,396 | $2.44 | $27,827.89 | -0.5% | -24.2% | +31.3% | |
| Jul 11, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 74,551 | $2.36 | $175,841.82 | -1.1% | -27.8% | +30.3% | |
| Jul 1, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 8,288 | $2.12 | $17,597.91 | -0.4% | -12.4% | +34.0% | |
| Jun 28, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 64,568 | $2.21 | $142,502.70 | -1.4% | -12.0% | +38.5% | |
| Jun 25, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 12,450 | $2.26 | $28,113.35 | -5.7% | -10.0% | +37.6% | |
| May 31, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 15,054 | $2.92 | $44,007.97 | -6.3% | -28.1% | +8.2% | |
| May 22, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 42,800 | $3.05 | $130,434.45 | -0.9% | -26.4% | +6.0% | |
| May 17, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 70,885 | $3.25 | $230,325.63 | -1.4% | -33.7% | +3.2% | |
| May 10, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 182,300 | $3.11 | $566,950.60 | -3.6% | -36.7% | +8.0% |